重组Anti-XCL1+XCL2抗体[EPR26181-30]
Anti-XCL1+XCL2 antibody [EPR26181-30]
- 20ul selling size
- RabMAb
- Recombinant
- 了解详情
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal XCL1 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra), IP and reacts with Human samples. Cited in 1 publication.
查看别名
LTN, SCYC1, XCL1, Lymphotactin, ATAC, C motif chemokine 1, Cytokine SCM-1, Lymphotaxin, SCM-1-alpha, Small-inducible cytokine C1, XC chemokine ligand 1
- ICC
Supplier Data
Immunocytochemistry - Anti-XCL1+XCL2 antibody [EPR26181-30] (AB302522)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized HEK-293T (human embryonic kidney epithelial cell) cells labelling XCL1+XCL2 with ab302522 at 1/100 (4.32 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 2 ug/ml dilution (Green). Confocal image showing cytoplasmic staining in HEK-293T cells transfected with a human SCN2A expression vector containing a myc-tag. is observed. Myc-Tag Mouse mAb (Alexa Fluor® 647) was used to counterstain tubulin at 1/100 0.38ug/ml dilution (Red). The Nuclear counterstain was DAPI (Blue). Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 2 ug/ml dilution.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-XCL1+XCL2 antibody [EPR26181-30] (AB302522)
Flow cytometric analysis of 2% paraformaldehyde fixed 0.1% Tween-20 permeabilized Human peripheral blood mononuclear cell (PBMC) treated with 80nM TPA, 1.3uM Ionomycin, 10uM BFA and 2uM Monensin for 6h (Right) / Untreated control (Left) cells labelling XCL1+XCL2 with ab302522 at 1/500 dilution (0.1ug)/ Left and Right (Red) compared with a isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/2000 dilution was used as the secondary antibody.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-XCL1+XCL2 antibody [EPR26181-30] (AB302522)
Flow cytometric analysis of 4% paraformaldehyde fixed 90% methanol permeabilized HuT-78 (human Sezary syndrome cutaneous T lymphocyte) treated with 80nM TPA and 3uM Ionomycin for 5h, then add 300ng/ml BFA for another 4h (Red) / Untreated control (Green) cells labelling XCL1+XCL2 with ab302522 at 1/500 dilution (0.1ug) (Red) (Red) compared with a Rabbit monoclonal IgG (ab172730) (Black) isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). A Goat Anti-Rabbit IgG (Alexa Fluor® 488, ab150081) at 1/2000 dilution was used as the secondary antibody.
- ICC
Supplier Data
Immunocytochemistry - Anti-XCL1+XCL2 antibody [EPR26181-30] (AB302522)
Immunofluorescent analysis of 4% Paraformaldehyde-fixed, 0.1% TritonX-100 permeabilized HuT-78 (human Sezary syndrome cutaneous T lymphocyte) cells labelling XCL1+XCL2 with ab302522 at 1/1000 (0.432 ug/ml) dilution, followed by ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed antibody at 1/1000 2 ug/ml dilution (Green). Confocal image showing increased cytoplasmic staining in HuT-78 cells treated with TPA (80 nM) and Ionomycin (3 uM) for 5 h, then add Brefeldin A (300ng/ml) for another 4 h is observed. ab195889 Anti-alpha Tubulin mouse monoclonal antibody - Microtubule Marker (Alexa Fluor® 594) was used to counterstain tubulin at 1/200 2.5ug/ml dilution (Red). The Nuclear counterstain was DAPI (Blue). Secondary antibody only control : Secondary antibody is ab150081 Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed at 1/1000 2 ug/ml dilution.
- WB
Supplier Data
Western blot - Anti-XCL1+XCL2 antibody [EPR26181-30] (AB302522)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
All lanes:
Western blot - Anti-XCL1+XCL2 antibody [EPR26181-30] (ab302522) at 1/500 dilution
Lane 1:
Human XCL1 recombinant protein at 10 ng
Lane 2:
Human XCL2 recombinant protein at 10 ng
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 12 kDa
Observed band size: 15 kDa
false
Exposure time: 15s
- WB
Supplier Data
Western blot - Anti-XCL1+XCL2 antibody [EPR26181-30] (AB302522)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
The expression of XCL1 are upregulated in response to TPA and Ionomycin treatment (PMID : 29474842, 32948687).
All lanes:
Western blot - Anti-XCL1+XCL2 antibody [EPR26181-30] (ab302522) at 1/500 dilution
Lane 1:
Untreated HuT-78 (human Sezary syndrome cutaneous T lymphocyte), whole cell lysate at 40 µg
Lane 2:
HuT-78 treated with 80 nM TPA and 3 uM Ionomycin for 5h, 300 ng/ml BFA was then added for additional 4h, whole cell lysate at 40 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 12 kDa
Observed band size: 15 kDa
false
Exposure time: 1s
不同偶联物与剂型 (1)
-
Anti-XCL1+XCL2 antibody [EPR26181-30] (BSA and Azide free)
反应性数据
产品详情
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存时间
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
XCL1 and XCL2 engage in guiding lymphocytes to the site where they are needed such as inflamed or infected tissue areas. They do not form part of larger protein complexes but function independently to attract specific types of immune cells. By binding to their receptor XCR1 on dendritic cells and other immune cells they instigate responses that are critical for initiating and regulating immune surveillance and responses.
Pathways
XCL1 and XCL2 are involved in the chemokine signaling pathway that orchestrates the movement and position of immune cells within tissues. They interact with proteins such as the XCR1 receptor on cell surfaces triggering signaling cascades that facilitate inflammatory responses. The chemokine signaling pathway is closely linked with other immune pathways such as the cytokine-cytokine receptor interaction pathway allowing cross-talk and intervention of various immune mediators.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
其他靶点
文献 (1)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:3516 PubMed40229254
2025
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com